Expert Interview
Looking at Revolution Medicine's RMC-6236 and the results to date prior to their RASolute 302 Phase 3 Trial
Ticker(s): RVMDInstitution: Moffitt
- GI Medical Oncology Assistant Member, department of GI Oncology - Moffitt
- Completed Melanoma Immunology Fellowship at MD Anderson and recently completed Medical Oncology Fellowship at Moffitt
- specialize in the treatment of gastrointestinal cancers, with a focus on immunotherapy.
Roughly how many pancreatic cancer patients do you manage?
Added By: ben_adminHow do you view the mechanism of action of RMC-6236?
Added By: ben_adminWhat is your impression of the side effect profile and efficacy demonstrated in Revolutions Phase 3 trial?
Added By: ben_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
